CHHS

After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at George Mason University and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.

Dean Melissa Perry appointed to prestigious National Academies of Sciences, Engineering, and Medicine Committee.

The Other Terrifying Deer Disease Creeping Across the U.S.

The COVID pandemic harmed trust in childhood vaccines and public health. What that means for future outbreaks.

Study highlights disparities in osteoporosis diagnosis across demographics.

George Mason professor and researcher recognized for critical research contributions in the field of behavioral medicine.

Miller is director of health services at USMC headquarters and vice chief, BUMED, Reserve Policy and Integration for the United States Department of Navy. She will speak at the College Degree Celebration at EagleBank Arena on May 17 at 2 pm.

After 30 years of outstanding service to George Mason University’s health administration and policy programs, distinguished leader and cherished member of the College of Public Health P.J. Maddox will retire at the end of the 2024-25 academic year. Maddox, who has served for 20 years as chair of the Department of Health Administration and Policy and is co-director of the Virginia Center for Health Workforce, leaves behind a legacy of unparalleled dedication, innovation, and impact.

Dr. Geschke is an instructional faculty member in the Department of Health Administration and Policy at George Mason University. With over 15 years of experience in higher education, she is dedicated to fostering student success through engaging, student-centered teaching.

Health care AI expert Farrokh Alemi highlights the underutilized power of predictive artificial intelligence to detect and prevent multiple common cancers.